A series of personal injury suits filed in Los Angeles earlier this month alleges that a charity established by the financier Michael Milken, in conjunction with prostate cancer researchers nationwide, engaged in systematic promotion of PC-Spes, a “nutraceutical” that was sold as a mixture of Chinese herbs, but was laced with prescription drugs.
Also in this 12-page issue: ASCO urges freeze of Medicare payments for chemotherapy at 2004 levels for next two years.
NCI director creates four new deputy director positions to manage the Institute.
Five NCAB members complete terms.
Breast surgeon and advocate Susan Love weds surgeon Helen Cooksey in San Francisco.
Funding opportunities listed.
NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.
Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Bhattacharya cancels NIH all-hands meeting
- In the Headlines: “There’s no one to stand up for NCI right now.”
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies
